Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock

Press/Media: Press / Media

PeriodFeb 13 2018 → Feb 14 2018

Media coverage

12

Media coverage

  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletUSA Life Sciences Database
    CountrySwitzerland
    Date2/14/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date2/14/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletIndia Pharma News
    CountryIndia
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletNasdaq
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletTradingCharts.com
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletCath Lab Digest
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletHealthcare Sales & Marketing Network
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletPharmaVOICE
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletPharmacy Choice
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletDaily Times Leader
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletGlobeNewswire
    CountryUnited States
    Date2/13/18
    PersonsDawn S Hui
  • TitleAbiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
    Media name/outletBizWire Express
    CountryIndia
    Date2/13/18
    PersonsDawn S Hui